FCNYX | MAFRX | FCNYX / MAFRX | |
Total Expense Ratio | 0.20 | 0.60 | 33% |
Annual Report Gross Expense Ratio | 0.25 | 0.60 | 42% |
Fund Existence | 2 years | 14 years | - |
Gain YTD | 2.262 | 2.499 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.52B | 7.81B | 96% |
Annual Yield % from dividends | 4.76 | 5.36 | 89% |
Returns for 1 year | 4.99 | 5.52 | 90% |
Returns for 3 years | N/A | 19.01 | - |
Returns for 5 years | N/A | 21.85 | - |
Returns for 10 years | N/A | 28.99 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ZVGNX | 56.37 | 1.21 | +2.19% |
Zevenbergen Genea Investor | |||
LCGFX | 31.45 | 0.46 | +1.48% |
William Blair Large Cap Growth I | |||
BRSDX | 14.57 | 0.12 | +0.83% |
MFS Blended Research Small Cap Eq A | |||
TADGX | 83.08 | 0.58 | +0.70% |
T. Rowe Price Dividend Growth Advisor | |||
AEMSX | 15.09 | 0.06 | +0.40% |
abrdn Emerging Markets Instl Svc |